Setting a New Standard for Treating CNS Diseases

We are Inhibikase Therapeutics, a pharmaceutical company innovating small-molecule kinase inhibitor therapeutics for the treatment of neurological infections and neurodegenerative diseases.

About Our Company

Targeted Therapies for Life-threatening Neurodegenerative Diseases

Our pipeline includes multiple products developed from our proprietary RAMP™ drug innovation and prodrug technology engines. Our programs are focused on halting and reversing the effects of neurodegenerative diseases inside and outside of the brain.  We are also developing host-targeted therapeutics for neurological infections in the brain.

Our Pipeline